⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RARE News
Ultragenyx Pharmaceutical Inc.
CLASS ACTION INVESTOR ALERTS: Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ultragenyx and Mereo BioPharma and Encourages Investors to Contact the Firm
globenewswire.com
RARE
MREO
Pomerantz LLP Informs Shareholders of Securities Class Action Filing Against Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE
Bronstein, Gewirtz & Grossman LLC Urges Ultragenyx Pharmaceutical Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
RARE
RARE Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages RARE Investors with Losses to Contact the Firm
prnewswire.com
RARE
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE
accessnewswire.com
RARE
Pomerantz LLP Notifies Investors of Class Action Against Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE
MREO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026 Ready to Announce with Confidence?
newsfilecorp.com
MREO
RARE
VTGN
RARE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026 Ready to Announce with Confidence?
newsfilecorp.com
RARE
RARE Shareholders Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
accessnewswire.com
RARE
Pomerantz LLP Informs Shareholders of Securities Class Action Against Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE